Literature DB >> 26110495

Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity.

A Yamamoto1, M Kawai1, K Iwanaga1, T Matsukura1, F Niwa1, T Hasegawa1, T Heike1.   

Abstract

OBJECTIVE: Whether hormone supplementation is necessary for infants with transient hypothyroxinemia of prematurity (THOP) remains controversial, and further analysis of the hypothalamus-pituitary-thyroid axis of infants with THOP is necessary. STUDY
DESIGN: Thyrotropin-releasing hormone (TRH) stimulation tests were performed at 2 weeks of age in 50 infants with a gestational age of 30 weeks or less, and the data were analyzed retrospectively. RESULT: Subjects were divided into three groups; group A consisted of euthyroid infants, group B consisted of infants with THOP and group C consisted of hypothyroid infants. The basal and peak thyroid-stimulating hormone level of group C in response to TRH stimulation tests was significantly higher than the others, but no differences were observed between groups A and B.
CONCLUSION: The response of infants with THOP to the TRH stimulation test was not different from that of euthyroid infants, which suggested that their hypothalamic-pituitary-thyroid axis was appropriately regulated in infants with THOP.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26110495     DOI: 10.1038/jp.2015.67

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  28 in total

Review 1.  Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.

Authors:  R Rapaport; S R Rose; M Freemark
Journal:  J Pediatr       Date:  2001-08       Impact factor: 4.406

2.  Thyroid function in preterm infants with respiratory distress syndrome.

Authors:  R A Cuestas; R R Engel
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

3.  Transient hypothyroxinaemia associated with developmental delay in very preterm infants.

Authors:  W J Meijer; S P Verloove-Vanhorick; R Brand; J L van den Brande
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

4.  Late-onset circulatory dysfunction after thyroid hormone treatment in an extremely low birth weight infant.

Authors:  Hideaki Yagasaki; Kisho Kobayashi; Atsushi Nemoto; Atsushi Naito; Kanji Sugita; Kenji Ohyama
Journal:  J Pediatr Endocrinol Metab       Date:  2010 Jan-Feb       Impact factor: 1.634

5.  Thyroid function in very preterm infants: influences of gestational age and disease.

Authors:  A G van Wassenaer; J H Kok; F W Dekker; J J de Vijlder
Journal:  Pediatr Res       Date:  1997-11       Impact factor: 3.756

6.  Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation.

Authors:  M L Reuss; A Leviton; N Paneth; M Susser
Journal:  Am J Public Health       Date:  1997-10       Impact factor: 9.308

7.  Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.

Authors:  A G van Wassenaer; J H Kok; J J de Vijlder; J M Briët; B J Smit; P Tamminga; A van Baar; F W Dekker; T Vulsma
Journal:  N Engl J Med       Date:  1997-01-02       Impact factor: 91.245

8.  Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.

Authors:  J M Briët; A G van Wassenaer; F W Dekker; J J de Vijlder; A van Baar; J H Kok
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

9.  The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants.

Authors:  A L Den Ouden; J H Kok; P H Verkerk; R Brand; S P Verloove-Vanhorick
Journal:  Pediatr Res       Date:  1996-01       Impact factor: 3.756

10.  Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation.

Authors:  Edmund F La Gamma; Aleid G van Wassenaer; Susana Ares; Sergio G Golombek; Joke H Kok; Jose Quero; Ting Hong; Mohammad H Rahbar; Gabriella Morreale de Escobar; Delbert A Fisher; Nigel Paneth
Journal:  Pediatrics       Date:  2009-07-05       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.